Corporate Banner
Satellite Banner
Technology Networks Header
Friday, April 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products>Product Directory
  Product Directory
Return to the previous page
Columns

C18 nec (23%) 2mL/200mg
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 2mL/50mg
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 300mg
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 3mL/200mg
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 3mL/500mg
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 600mg
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 6mL/1g
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 6mL/2g
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 6mL/500mg
Greyhound Chromatography - Products
Request a quote
More information
C18 nec (23%) 900mg
Greyhound Chromatography - Products
Request a quote
More information
<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 95
Scientific News
Diagnosis of Bladder Cancer and Prediction of Survival by Urinary Metabolomics
Bladder cancer seems to be ideal for urinary metabolomics-based diagnosis, as urine can directly contact the cancer lesion in the bladder.
A Metabolomic Perspective on Coeliac Disease
Metabolomics has proved to be a useful complement for the characterization of several physiological and pathological conditions and offers promises as a clinical tool.
Underlying Genetics and Marker For Stroke Discovered
NIH-funded findings point to new potential strategies for disease prevention, treatment.
BIOCRATES Test Kit Helps Develop First Metabolomics-Based Blood Test for Alzheimer’s
The test is capable of predicting, with 90% accuracy, the risk of Alzheimer’s disease 2–3 years before it has actually become clinically manifest.
The Role of Mass Spectrometry in the "Omics" Era
The tremendous developments of the MS technology and concurrent gene sequencing efforts have made the “-omic” revolution possible.
Metabolomics: Taking Aim at Diabetic Kidney Failure
Krolewski and his Joslin colleagues search for better ways of predicting which diabetic people are at risk for ESRD.
Omega-3 Fatty Acids have Wider Range of Biological Impacts
Study explored the challenges the liver faces from the “Western diet” that increasingly is linked to liver inflammation, fibrosis, cirrhosis and sometimes liver failure.
Speeding Validation of Disease Targets
NIH, industry and non-profits join forces to develop new treatments earlier, beginning with Alzheimer’s, type 2 diabetes, and autoimmune disorders.
Fatty Liver Disease Reversed in Mice
Epilepsy drug also shown to decrease obesity-related blood sugar levels.
GW Receives up to $14.6M to Develop Method for Characterizing Security Threats
The researchers are tasked with reducing to 30 days a process that can sometimes take years or even decades.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv